Patents by Inventor Guangheng Zhu

Guangheng Zhu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8323652
    Abstract: This application relates to agents capable of specifically recognizing GPIb?, a key receptor required for platelet adhesion and aggregation. More specifically, this application relates to monoclonal antibodies and derivatives thereof capable of specifically recognizing both the murine and the human GPIb?. These monoclonal antibodies and derivatives are particularly useful in the treatment or prevention of thrombosis as well as research tools.
    Type: Grant
    Filed: November 13, 2009
    Date of Patent: December 4, 2012
    Assignee: Canadian Blood Services
    Inventors: Heyu Ni, Guangheng Zhu
  • Publication number: 20100150837
    Abstract: This application relates to agents capable of specifically recognizing GPIb?, a key receptor required for platelet adhesion and aggregation. More specifically, this application relates to monoclonal antibodies and derivatives thereof capable of specifically recognizing both the murine and the human GPIb?. These monoclonal antibodies and derivatives are particularly useful in the treatment or prevention of thrombosis as well as research tools.
    Type: Application
    Filed: November 13, 2009
    Publication date: June 17, 2010
    Inventors: Heyu Ni, Guangheng Zhu
  • Patent number: 7731966
    Abstract: Monoclonal antibodies prepared against platelet ?3 integrin useful in antithrombotic therapy or in models of thrombosis, thrombocytopenia, and anti-angiogenesis. The antibodies are prepared using ?3 integrin deficient (?3?/?) mice immunized against platelets or ?3 integrin fragments.
    Type: Grant
    Filed: April 11, 2008
    Date of Patent: June 8, 2010
    Assignee: Canadian Blood Services
    Inventors: Heyu Ni, Guangheng Zhu
  • Publication number: 20090047290
    Abstract: Monoclonal antibodies prepared against platelet ?3 integrin useful in antithrombotic therapy or in models of thrombosis, thrombocytopenia, and anti-angiogenesis. The antibodies are prepared using ?3 integrin deficient (?3?/?) mice immunized against platelets or ?3 integrin fragments.
    Type: Application
    Filed: April 11, 2008
    Publication date: February 19, 2009
    Applicant: CANADIAN BLOOD SERVICES
    Inventors: Heyu Ni, Guangheng Zhu